Orifarm Manufacturing Poland Sp. z o.o. is part of the Orifarm Group healthcare platform in Poland, combining pharmaceutical production capacity with commercialization and distribution activities across regulated and consumer healthcare categories. Business segments include consumer healthcare (dietary supplements and wellness products such as vitamins, minerals, fish oil and probiotics), over-the-counter medicines addressing common conditions (including pain/fever relief, cold and allergy symptoms, decongestants and bone health), and parallel import operations within the EU that involve sourcing original medicines in EU markets, repackaging and relabeling for local-market requirements, and resale in Poland and other markets. The Polish footprint includes a pharmaceutical manufacturing facility in Lyszkowice described as a modern production plant supporting the companys position in Poland and international markets, complemented by capabilities in repackaging and localization for parallel-import medicines. Key brands marketed in Poland under the Orifarm Healthcare portfolio include Amol, Febrisan, Multi-Sanostol, Vita Buerlecithin, Vitrum and Arthron Complex, spanning OTC and supplement categories. Geographic reach includes Poland and cross-border EU sourcing and supply chains, with Orifarm positioning itself as a provider of affordable, high-quality healthcare products and as a large player in EU parallel import, leveraging access to suppliers and markets. Strategic focus is on improving affordability and availability of healthcare products, expanding product lines and market presence, and scaling manufacturing and operational capabilities to support growth across regulated pharmaceutical and consumer-health segments.
Headquarters
Ul. Ksiestwa Lowickiego 12
Lyszkowice; Lodzkie;
Postal Code: 99-420
Contact Details: Purchase the Orifarm Manufacturing Poland Sp. z o.o. report to view the information.
Website: https://www.orifarmhealth.pl/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service